175 related articles for article (PubMed ID: 20484215)
1. Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion.
Crill CM; Hak EB; Robinson LA; Helms RA
Am J Health Syst Pharm; 2010 Jun; 67(11):914-8. PubMed ID: 20484215
[TBL] [Abstract][Full Text] [Related]
2. Effect of 24-hour intravenous tubing set change on the sterility of repackaged fat emulsion in neonates.
Reiter PD; Robles J; Dowell EB
Ann Pharmacother; 2004 Oct; 38(10):1603-7. PubMed ID: 15328398
[TBL] [Abstract][Full Text] [Related]
3. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality.
Stucki C; Sautter AM; Favet J; Bonnabry P
Am J Health Syst Pharm; 2009 Nov; 66(22):2032-6. PubMed ID: 19890087
[TBL] [Abstract][Full Text] [Related]
4. Multiple withdrawals from single-use vials: a study on sterility.
Ripoll Gallardo A; Meneghetti G; Ragazzoni L; Kroumova V; Ferrante D; Ingrassia PL; Ruzza P; Dell'Era A; Boniolo E; Koraqe G; Faggiano F; Della Corte F
Int J Pharm; 2015 May; 485(1-2):160-3. PubMed ID: 25769293
[TBL] [Abstract][Full Text] [Related]
5. Sterility of pediatric lipid emulsions repackaged by an automated compounding device.
Ybarra JV; Rose WE; Curtis CS; Sacks GS
JPEN J Parenter Enteral Nutr; 2011 May; 35(3):391-4. PubMed ID: 21527602
[TBL] [Abstract][Full Text] [Related]
6. Physical stability of 20% lipid injectable emulsions via simulated syringe infusion: effects of glass vs plastic product packaging.
Driscoll DF; Ling PR; Bistrian BR
JPEN J Parenter Enteral Nutr; 2007; 31(2):148-53. PubMed ID: 17308256
[TBL] [Abstract][Full Text] [Related]
7. Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system.
Krämer I; Federici M
Eur J Hosp Pharm; 2020 Jul; 27(4):209-215. PubMed ID: 32587079
[TBL] [Abstract][Full Text] [Related]
8. Compounding times and contamination rates associated with the preparation of intravenous admixtures in three types of plastic containers.
Allinson RR; Stach PE; Sherrin TP; Latiolais CJ
Am J Hosp Pharm; 1979 Apr; 36(4):513-7. PubMed ID: 433938
[TBL] [Abstract][Full Text] [Related]
9. Parenterals laboratory course to reduce microbial contamination rates in media fill tests performed by pharmacy students.
Isanhart CM; McCall KL; Kretschmer D; Grimes BA
Am J Pharm Educ; 2008 Apr; 72(2):27. PubMed ID: 18483595
[TBL] [Abstract][Full Text] [Related]
10. Microbial stability of syringes of anesthetic drugs prepared in the operating room.
Segal S; Gunawan A; McLaughlin DH; Palavecino E
J Clin Anesth; 2019 Aug; 55():20-23. PubMed ID: 30586662
[TBL] [Abstract][Full Text] [Related]
11. A protocol for microbiologically safe preparation, storage, and use of autologous serum eye-drops in low-income countries.
Blasetti F; Usai D; Sotgia S; Carru C; Zanetti S; Pinna A
J Infect Dev Ctries; 2015 Jan; 9(1):55-9. PubMed ID: 25596572
[TBL] [Abstract][Full Text] [Related]
12. Microbiologic quality assurance for intravenous admixtures in a small hospital.
Doss HL; James JD; Killough DM; Snodgrass GL
Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab.
Crul M; Zandvliet A; Moes JR; Veenbaas T; Smeets O
J Ocul Pharmacol Ther; 2019; 35(6):372-375. PubMed ID: 31259653
[No Abstract] [Full Text] [Related]
14. Non-destructive vacuum decay method for pre-filled syringe closure integrity testing compared with dye ingress testing and high-voltage leak detection.
Simonetti A; Amari F
PDA J Pharm Sci Technol; 2015; 69(1):108-22. PubMed ID: 25691719
[TBL] [Abstract][Full Text] [Related]
15. The incidence and clinical significance of intravenous fat emulsion contamination during infusion.
Ebbert ML; Farraj M; Hwang LT
JPEN J Parenter Enteral Nutr; 1987; 11(1):42-5. PubMed ID: 3102780
[TBL] [Abstract][Full Text] [Related]
16. A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing.
Boullata JI; Gilbert K; Sacks G; Labossiere RJ; Crill C; Goday P; Kumpf VJ; Mattox TW; Plogsted S; Holcombe B;
JPEN J Parenter Enteral Nutr; 2014; 38(3):334-77. PubMed ID: 24531708
[TBL] [Abstract][Full Text] [Related]
17. Microbial growth patterns in intravenous fat emulsions.
Keammerer D; Mayhall CG; Hall GO; Pesko LJ; Thomas RB
Am J Hosp Pharm; 1983 Oct; 40(10):1650-3. PubMed ID: 6416063
[TBL] [Abstract][Full Text] [Related]
18. Bacterial contamination of propofol: the effects of temperature and lidocaine.
Aydin N; Aydin N; Gultekin B; Ozgun S; Gurel A
Eur J Anaesthesiol; 2002 Jun; 19(6):455-8. PubMed ID: 12094922
[TBL] [Abstract][Full Text] [Related]
19. Using medium-fill simulation to establish a benchmark microbiological contamination rate for low-risk-level compounding.
Trissel LA; Ogundele AB; Ingram DS; Saenz CA; Gentempo JA
Am J Health Syst Pharm; 2003 Sep; 60(18):1853-5. PubMed ID: 14521036
[TBL] [Abstract][Full Text] [Related]
20. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
